Former pharma exec-turned best-selling author and coach, offers a solution to those feeling the work-life balance strain

Company defends class action in the Federal Court over products it's claimed did not provide clinically significant benefit

Seventh country head to leave Australia in the last three months with her replacement already named

Which companies have made Great Place to Work's prestigious top pharma and biotechs in ANZ list?

November Agenda update reveals this company is going another round with PBAC, its third attempt this year

Industry body welcomes a new pharma looking to strengthen partnerships and contribute to patient-focused healthcare

After 10 months in limbo, the FDA's change of heart clears the way for promising flagship drug to enter Phase 2/3 trials this year

Summit unpacks the link between speedy access to innovative treatments and national productivity

One new drug and two new forms of already approved medicines have been listed on the ARTG

The shortlist for the prestigious Golden Target Awards feature pharma campaigns and the agencies they work with

ICYMI: Another company walks away from PBS negotiations plus the other most popular stories this week

Locally developed framework defines competency levels of medical affairs work, allowing professionals to demonstrate value they bring to pharma

Manufacturing problems the cause of a shortage which saw supply of this critical drug dry up in 2023

Industry report find more than half of employees believe their workplace culture is only moderately healthy... or worse

Century old drug, normally administered by injection, halves the risk of death by respiratory infection when inhaled

Chief Financial Officer announces retirement amid major restructure with Chief Strategy Officer tapped to take over the role

The wash-up for PBS listings this month reveals six medicines have won reimbursement with one company scoring a double win

The TGA has accepted 21 drugs for evaluation, with almost half of them new to the Australian market